Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neixiao Luoli Pill
- Development stage
- Phase 4
- Lead developer
- Zhejiang Provincial People's Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Neixiao Luoli Pill is a traditional Chinese patent medicine (TCPM) formulated to "soften hardness and dissipate nodules," a therapeutic principle in Chinese medicine used to treat masses and swellings. It is composed of a complex mixture of herbal ingredients, typically including *Prunella vulgaris* (Xiaoku Cao), *Scrophularia ningpoensis* (Xuan Shen), *Sargassum* (Hai Zao), and *Rehmannia glutinosa* (Di Huang), among others. The pill is traditionally indicated for scrofula (cervical lymphadenitis), goiter, and other subcutaneous swellings. In modern clinical research, particularly in trials led by Zhejiang Provincial People's Hospital, it is being evaluated for its efficacy and safety in treating benign or low-risk thyroid nodules. The mechanism is thought to involve anti-inflammatory and anti-proliferative effects that promote the reduction of nodule size and improve ultrasound findings and related symptoms.
- Brand names
- Neixiao Luoli Pill
- Other names
- Neixiao Luoli WanNeixiao Luoli Pills内消瘰疬丸
Beyond the preview
Go deeper on Neixiao Luoli Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neixiao Luoli Pill.